ApprovedNeuroendocrine / Cushing

Pasireotide

Brand examples:SigniforSignifor LAR

Class
Neuroendocrine / Cushing
Route
SC / IM depot
Frequency
Twice daily or monthly
GLP-1 relevance
No

How it works

Somatostatin analog

Approved & studied uses

Cushing disease; acromegaly

Regulatory status

Approved

Safety notes

Prescription-only.

Sources

Educational reference only. This page does not provide diagnosis, dosing, titration or treatment recommendations. Peptimize does not recommend or adjust any medication schedule - that is between you and your prescriber.